In his annual shareholder letter, JPMorgan CEO Jamie Dimon pointed to data showing a radically shrinking U.S. stock market, echoing an increasingly common refrain on Wall Street and in corporate America. Dimon is working alongside business luminaries such as Warren Buffett, BlackRock’s Larry Fink and GM CEO Mary Barra to promote long-term stock market investment and regulations that will....More>>>
Corcept Therapeutics (NASDAQ:CORT) is my favorite type of biotech company. It has an approved, marketed product with ramping sales, promising pipeline candidates, and is beginning to turn a profit. Both guidance by the company and analyst coverage suggest substantial growth in earnings and revenue. While not without the inherent risks of investing in a small/mid-cap biotech companies,....More>>>
For retirement savers, a new era of clarity was supposed to dawn in April. Instead, they’ve been left in the fog.
SEE ALSO: 10 Financial Decisions That Will Haunt You Forever
A U.S. Department of Labor rule that was set to take effect April 10 would have made all financial professionals offering advice on retirement accounts subject to a “fiduciary” duty to....More>>>
As Wall Street celebrates the eighth anniversary of the cyclical bull market on Thursday, two things stand out: a knock in oil prices amid a supply glut and high levels of pessimism that appear at odds with near-record levels of stock-market indexes.
Just when traders became comfortable, a jump in U.S. crude supplies knocked oil prices ....More>>>
William Patalon III
Two of our stocks are having big days today – thanks to better-than-expected earnings reports.
Both are industrial plays.
And both can be bought here.
One of the stocks is a direct play on the semiconductor-equipment business – a sector whose bullish outlook we detailed in a recent two-day report (Part I and Part II). The other is....More>>>
Tesla is set to reap massive revenues from the industry which powers every other one: energy. Solar energy will power TSLA stock going forward.
Since its IPO in 2010, Tesla (NSDQ:TSLA) has had short periods of volatility and also uncertainty about its viability as a game-changing company. Elon Musks ambitious projects had raised some eyebrows on the Wall Street. However, recent developments....More>>>
Thesis: The threat to enforce federal marijuana laws might backfire by pushing Congress to legalize marijuana on the federal level. While in the short term, marijuana related stocks might suffer, if legislation is passed and signed into law, it would not only ease fears, but also make it more likely that more states will follow along with the pot legalization trend. This will have a long term positive....More>>>
U.S. equities continued their post-election, pre-holiday climb on Tuesday with the Dow Jones Industrial Average inching ever closer to the 20,000 threshold. News flow was light, focused on terror attacks in Europe and the prospect of fiscal policy easing from the incoming Trump Administration.
In the end, the Dow gained 0.5%, the S&P 500 gained 0.4%, the Nasdaq Composite wafted....More>>>
Wells Fargo & Co (NYSE: WFC) shareholders were caught completely off guard by the extent of the companys fraudulent behavior related to its recent $185 million settlement, and now Wells Fargo CEO John Stumpf is getting taken to the woodshed by Senator Elizabeth Warren and others on the Senate Banking Committee.
SEE ALSO FROM KIPLINGER: 7 Great Credit Unions Anyone Can Join
AQR Capital Management’s Cliff Asness has launched a healthy discussion about the trials and tribulations of factor timing with a new essay (“The Siren Song of Factor Timing”). He’s recommends that investors steer clear, which is good advice because the crowd’s record, in the aggregate, to successfully engage in market-timing activities generally is overwhelmingly poor.....More>>>